Fluorine in PDB 6hhr: HSP90 in Complex with 5-(2,4-Dihydroxy-Phenyl)-4-(2-Fluoro-Phenyl)-2, 4-Dihydro-[1,2,4]Triazole-3-Thione
Protein crystallography data
The structure of HSP90 in Complex with 5-(2,4-Dihydroxy-Phenyl)-4-(2-Fluoro-Phenyl)-2, 4-Dihydro-[1,2,4]Triazole-3-Thione, PDB code: 6hhr
was solved by
D.Musil,
M.Lehman,
H.-M.Eggenweiler,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
34.66 /
2.00
|
Space group
|
I 2 2 2
|
Cell size a, b, c (Å), α, β, γ (°)
|
65.830,
89.410,
99.330,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
18.3 /
20.7
|
Fluorine Binding Sites:
The binding sites of Fluorine atom in the HSP90 in Complex with 5-(2,4-Dihydroxy-Phenyl)-4-(2-Fluoro-Phenyl)-2, 4-Dihydro-[1,2,4]Triazole-3-Thione
(pdb code 6hhr). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 2 binding sites of Fluorine where determined in the
HSP90 in Complex with 5-(2,4-Dihydroxy-Phenyl)-4-(2-Fluoro-Phenyl)-2, 4-Dihydro-[1,2,4]Triazole-3-Thione, PDB code: 6hhr:
Jump to Fluorine binding site number:
1;
2;
Fluorine binding site 1 out
of 2 in 6hhr
Go back to
Fluorine Binding Sites List in 6hhr
Fluorine binding site 1 out
of 2 in the HSP90 in Complex with 5-(2,4-Dihydroxy-Phenyl)-4-(2-Fluoro-Phenyl)-2, 4-Dihydro-[1,2,4]Triazole-3-Thione
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 1 of HSP90 in Complex with 5-(2,4-Dihydroxy-Phenyl)-4-(2-Fluoro-Phenyl)-2, 4-Dihydro-[1,2,4]Triazole-3-Thione within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F301
b:40.8
occ:0.50
|
F19
|
A:G5E301
|
0.0
|
40.8
|
0.5
|
C13
|
A:G5E301
|
1.4
|
39.2
|
0.5
|
C17
|
A:G5E301
|
1.5
|
35.1
|
0.5
|
C12
|
A:G5E301
|
2.2
|
33.1
|
0.5
|
C12
|
A:G5E301
|
2.4
|
36.2
|
0.5
|
C14
|
A:G5E301
|
2.4
|
38.6
|
0.5
|
N11
|
A:G5E301
|
2.5
|
31.7
|
0.5
|
C16
|
A:G5E301
|
2.7
|
34.8
|
0.5
|
N11
|
A:G5E301
|
2.7
|
34.3
|
0.5
|
O
|
A:LEU107
|
2.8
|
37.2
|
0.5
|
C10
|
A:G5E301
|
2.9
|
32.5
|
0.5
|
O
|
A:LEU107
|
2.9
|
37.5
|
0.5
|
S18
|
A:G5E301
|
3.1
|
35.0
|
0.5
|
C10
|
A:G5E301
|
3.2
|
34.5
|
0.5
|
CA
|
A:GLY108
|
3.2
|
36.5
|
1.0
|
O
|
A:HOH444
|
3.4
|
58.4
|
1.0
|
S18
|
A:G5E301
|
3.4
|
38.6
|
0.5
|
C13
|
A:G5E301
|
3.4
|
32.4
|
0.5
|
C
|
A:LEU107
|
3.5
|
38.0
|
0.5
|
C
|
A:LEU107
|
3.5
|
38.4
|
0.5
|
C7
|
A:G5E301
|
3.5
|
30.7
|
0.5
|
O
|
A:GLY108
|
3.6
|
43.7
|
1.0
|
C7
|
A:G5E301
|
3.6
|
32.8
|
0.5
|
C17
|
A:G5E301
|
3.6
|
35.8
|
0.5
|
C15
|
A:G5E301
|
3.7
|
37.7
|
0.5
|
N
|
A:GLY108
|
3.7
|
35.7
|
1.0
|
C
|
A:GLY108
|
3.7
|
42.9
|
1.0
|
SD
|
A:MET98
|
3.7
|
35.7
|
1.0
|
C15
|
A:G5E301
|
3.8
|
34.0
|
0.5
|
N9
|
A:G5E301
|
3.9
|
30.4
|
0.5
|
C5
|
A:G5E301
|
4.0
|
30.4
|
0.5
|
C5
|
A:G5E301
|
4.0
|
28.3
|
0.5
|
CG
|
A:MET98
|
4.1
|
33.0
|
1.0
|
C14
|
A:G5E301
|
4.1
|
32.9
|
0.5
|
N9
|
A:G5E301
|
4.1
|
32.3
|
0.5
|
C16
|
A:G5E301
|
4.1
|
36.3
|
0.5
|
N8
|
A:G5E301
|
4.2
|
30.9
|
0.5
|
C4
|
A:G5E301
|
4.3
|
29.1
|
0.5
|
C4
|
A:G5E301
|
4.3
|
31.2
|
0.5
|
N8
|
A:G5E301
|
4.4
|
32.7
|
0.5
|
F19
|
A:G5E301
|
4.4
|
32.7
|
0.5
|
O
|
A:HOH496
|
4.5
|
34.2
|
1.0
|
N
|
A:THR109
|
4.7
|
37.7
|
1.0
|
CA
|
A:LEU107
|
4.8
|
34.1
|
0.5
|
CA
|
A:LEU107
|
4.8
|
33.1
|
0.5
|
|
Fluorine binding site 2 out
of 2 in 6hhr
Go back to
Fluorine Binding Sites List in 6hhr
Fluorine binding site 2 out
of 2 in the HSP90 in Complex with 5-(2,4-Dihydroxy-Phenyl)-4-(2-Fluoro-Phenyl)-2, 4-Dihydro-[1,2,4]Triazole-3-Thione
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 2 of HSP90 in Complex with 5-(2,4-Dihydroxy-Phenyl)-4-(2-Fluoro-Phenyl)-2, 4-Dihydro-[1,2,4]Triazole-3-Thione within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F301
b:32.7
occ:0.50
|
F19
|
A:G5E301
|
0.0
|
32.7
|
0.5
|
C13
|
A:G5E301
|
1.3
|
32.4
|
0.5
|
C17
|
A:G5E301
|
1.4
|
35.8
|
0.5
|
C12
|
A:G5E301
|
2.2
|
36.2
|
0.5
|
C12
|
A:G5E301
|
2.4
|
33.1
|
0.5
|
C14
|
A:G5E301
|
2.4
|
32.9
|
0.5
|
C16
|
A:G5E301
|
2.4
|
36.3
|
0.5
|
N11
|
A:G5E301
|
2.6
|
34.3
|
0.5
|
N11
|
A:G5E301
|
2.7
|
31.7
|
0.5
|
O
|
A:ASN51
|
2.8
|
30.3
|
1.0
|
N
|
A:ALA55
|
3.0
|
29.0
|
1.0
|
C10
|
A:G5E301
|
3.2
|
34.5
|
0.5
|
C10
|
A:G5E301
|
3.3
|
32.5
|
0.5
|
CB
|
A:ALA55
|
3.3
|
27.2
|
1.0
|
CA
|
A:ALA55
|
3.4
|
28.0
|
1.0
|
C13
|
A:G5E301
|
3.4
|
39.2
|
0.5
|
C7
|
A:G5E301
|
3.4
|
30.7
|
0.5
|
C7
|
A:G5E301
|
3.4
|
32.8
|
0.5
|
C15
|
A:G5E301
|
3.6
|
37.7
|
0.5
|
C
|
A:ASP54
|
3.6
|
33.0
|
1.0
|
CB
|
A:ASP54
|
3.6
|
30.0
|
1.0
|
C17
|
A:G5E301
|
3.6
|
35.1
|
0.5
|
S18
|
A:G5E301
|
3.6
|
38.6
|
0.5
|
C15
|
A:G5E301
|
3.6
|
34.0
|
0.5
|
C
|
A:ASN51
|
3.9
|
31.5
|
1.0
|
C4
|
A:G5E301
|
3.9
|
29.1
|
0.5
|
C14
|
A:G5E301
|
3.9
|
38.6
|
0.5
|
S18
|
A:G5E301
|
3.9
|
35.0
|
0.5
|
C4
|
A:G5E301
|
3.9
|
31.2
|
0.5
|
N9
|
A:G5E301
|
4.1
|
32.3
|
0.5
|
C16
|
A:G5E301
|
4.1
|
34.8
|
0.5
|
CA
|
A:ASP54
|
4.1
|
28.6
|
1.0
|
N9
|
A:G5E301
|
4.1
|
30.4
|
0.5
|
N8
|
A:G5E301
|
4.2
|
30.9
|
0.5
|
N8
|
A:G5E301
|
4.2
|
32.7
|
0.5
|
CA
|
A:ASN51
|
4.3
|
29.8
|
1.0
|
O
|
A:ASP54
|
4.3
|
32.8
|
1.0
|
C3
|
A:G5E301
|
4.4
|
28.9
|
0.5
|
F19
|
A:G5E301
|
4.4
|
40.8
|
0.5
|
C3
|
A:G5E301
|
4.4
|
31.0
|
0.5
|
O20
|
A:G5E301
|
4.5
|
28.5
|
0.5
|
C5
|
A:G5E301
|
4.5
|
30.4
|
0.5
|
C5
|
A:G5E301
|
4.5
|
28.3
|
0.5
|
NZ
|
A:LYS58
|
4.5
|
80.1
|
1.0
|
O20
|
A:G5E301
|
4.6
|
30.4
|
0.5
|
N
|
A:ASP54
|
4.7
|
28.0
|
1.0
|
CB
|
A:ASN51
|
4.7
|
29.1
|
1.0
|
CD
|
A:LYS58
|
4.9
|
55.2
|
1.0
|
CG
|
A:ASP54
|
4.9
|
38.4
|
1.0
|
C
|
A:ALA55
|
4.9
|
30.6
|
1.0
|
N
|
A:SER52
|
5.0
|
26.4
|
1.0
|
|
Reference:
D.A.Schuetz,
M.Bernetti,
M.Bertazzo,
D.Musil,
H.M.Eggenweiler,
M.Recanatini,
M.Masetti,
G.F.Ecker,
A.Cavalli.
Predicting Residence Time and Drug Unbinding Pathway Through Scaled Molecular Dynamics. J.Chem.Inf.Model. V. 59 535 2019.
ISSN: ESSN 1549-960X
PubMed: 30500211
DOI: 10.1021/ACS.JCIM.8B00614
Page generated: Thu Aug 1 21:09:31 2024
|